PF-Atlas › Clinical Trials › NCT02315898

Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis

Treatment-inhaled tPA · Phase 2

Registry ID
NCT02315898
Phase
Phase 2
Status
Completed
Drug / intervention
Treatment-inhaled tPA
Sponsor
University of Michigan
Start
2018-03-19

About this trial

Treatment-inhaled tPA is evaluated in NCT02315898, a Phase 2 idiopathic pulmonary fibrosis study sponsored by University of Michigan. Current status: Completed.

View NCT02315898 on ClinicalTrials.gov →

Explore related

All Treatment-inhaled tPA trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT02315898 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.